RENEW OR SUBSCRIBE TO PPM
Subscription is FREE for qualified healthcare professionals in the US.
12 Articles in Volume 17, Issue #2
Chronic Pain and Bipolar Disorders: A Bridge Between Depression and Schizophrenia Spectrum
Differences in Pain Management of Peripheral Vascular Disease and Peripheral Artery Disease
Duloxetine and Liver Function Tests
How Well Do You Know Your Patient?
Insurers End Policies Requiring Prior Authorization for Opioid Use Disorder
Letters to the Editor: Initiating Hormones
Managing Opioid Use Disorders and Chronic Pain
Opportunities and Challenges of Pain Management: The Family Physician’s Perspective
Pathways to Recovery From Co-Occurring Chronic Pain and Addiction
Strategies for Weaning Opioids in Patients With an Opioid Use Disorder and Chronic Pain
Treating Multiple Pain Syndromes: A Case Series Using a Functional Medicine Model
Treatment of Chronic Exhaustion and Chronic Fatigue Syndrome

Insurers End Policies Requiring Prior Authorization for Opioid Use Disorder

Movement is being made to end prior authorization policies that delay or deny care for substance abuse disorders. Insurers Anthem and Cigna discontinued policies that require preauthorization for opioid use disorder treatments, following a settlement with New York Attorney General Eric T. Schneiderman.1,2

Managing opioid use disorders.

 

In February 2017, the American Medical Association (AMA) urged other state attorneys general to help end insurance company policies that delay or deny care for substance use disorders.3

In addition, the AMA called on all payers “to end policies that require patients to repeat step therapy protocols or retry therapies failed under other benefit plans before qualifying for coverage of a current effective therapy for substance use disorders.”

Last updated on: March 17, 2017
Continue Reading:
How Well Do You Know Your Patient?

Join The Conversation

Register or Log-in to Join the Conversation
SHOW MAIN MENU
SHOW SUB MENU